Mannatech Inc $MTEX
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Medicinal Chemicals & Botanical Products
- Headquarters
- Flower Mound, TX
- Fiscal year end
- December 31
- Shares outstanding
- 1,929,670 [10-Q 2026-08-12]
What the company doesAI summary of filing
Mannatech, Incorporated develops and sells nutritional supplements, skin care products, and weight-management products. The company distributes its products primarily through network marketing channels via independent associates and preferred customers in markets across the Americas, Europe, the Middle East, Africa, and Asia-Pacific, as well as through a cross-border e-commerce subsidiary in China. The company is revenue-generating, with approximately 114,000 active associate and preferred customer positions as of December 31, 2025. Mannatech makes money through commissions and incentives paid to independent associates based on product sales, with commission rates ranging from 35 to 43 percent of consolidated net sales. [10-K 2026-04-15]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $51.57M | $1.97M | $334.0K | $6.03M | [10-Q 2026-08-12] |
| FY ended Dec 2025 | $108.04M | −$15.20M | −$2.96M | $6.18M | [10-K 2026-04-15] |
| FY ended Dec 2024 | $117.87M | $2.50M | $2.26M | $11.40M | [10-K 2026-04-15] |
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-07-31 | 1,884,814 | [10-Q 2024-08-13] |
| 2024-10-31 | 1,884,814 | [10-Q 2024-11-12] |
| 2025-03-18 | 1,900,930 | [10-K 2025-03-26] |
| 2025-05-06 | 1,900,930 | [10-Q 2025-05-13] |
| 2025-11-04 | 1,900,930 | [10-Q 2025-11-12] |
| 2026-04-08 | 1,929,670 | [10-K 2026-04-15] |
| 2026-05-05 | 1,929,670 | [10-Q 2026-05-14] |
| 2026-08-05 | 1,929,670 | [10-Q 2026-08-12] |
Listing status
Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-04-24. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-04-24 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-04-24] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-05-20 | Jobe Larry A | buy | 2,803 | $4.12 | [4 2026-05-21] |
| 2026-05-19 | Jobe Larry A | buy | 5,000 | $4.20 | [4 2026-05-20] |
| 2026-05-19 | Robbins Kevin Andrew | buy | 7,100 | $4.17 | [4 2026-05-20] |
| 2026-01-02 | Jobe Larry A | grant | 4,790 | $8.35 | [4 2026-01-06] |
| 2026-01-02 | Robbins Kevin Andrew | grant | 4,790 | $8.35 | [4 2026-01-06] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-09-01 | 8-K | Director or officer change |
| 2026-08-19 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-19 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-12 | 8-K | Results of operations |
| 2026-08-12 | 10-Q | Quarterly report |
| 2026-06-08 | 8-K | Director or officer change |
| 2026-06-03 | 8-K | Shareholder vote results |
| 2026-05-14 | 8-K | Results of operations |
| 2026-05-14 | 10-Q | Quarterly report |
| 2026-04-24 | 8-K | Listing notice or transfer |
| 2026-04-24 | 13D | Beneficial ownership report (5%+ holder) |
| 2026-04-21 | DEF 14A | Proxy statement |
Alerts for $MTEX
Email me when Mannatech Inc files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.